Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Clinical Trial of Glyburide (RP-1127) for TBI

NCT01454154 is registered in ClinicalTrials.gov with Remedy Pharmaceuticals, Inc. as lead sponsor.

NCT NCT01454154
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01454154 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Clinical Trial of Glyburide (RP-1127) for TBI
Lead sponsor
Remedy Pharmaceuticals, Inc.
Phase
Phase 2
Overall status
Completed
Start date
December 17, 2011
Completion date
February 20, 2015
Enrollment
29 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

traumatic brain injury